Literature DB >> 1690196

Neural basis for regulation of cochlear blood flow: peptidergic and adrenergic innervation of the spiral modiolar artery of the guinea pig.

L Carlisle1, J Aberdeen, A Forge, G Burnstock.   

Abstract

The spiral modiolar artery is the terminal artery in the cochlea, and as such is expected to play a major role in the control of cochlear blood flow. In this study, we examined the distribution of adrenergic and peptidergic nerve fibres on the spiral modiolar artery of the guinea pig using histofluorescence and immunofluorescence techniques. The spiral modiolar artery was dissected from the modiolus so that the entire length of the vessel and its branches, could be observed. Noradrenaline was identified using the glyoxylic acid histofluorescence technique. The presence of the vasoactive peptides substance P, calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), was investigated using antibodies against these peptides. Each putative transmitter tested yielded labelled nerve fibres throughout the length of the spiral modiolar artery and its branches. Double-labelling experiments confirmed that CGRP and substance P are contained in the same fibres but that VIP and substance P appear to be contained in different populations of fibres. These results establish that nerve fibres containing vasoactive peptides and noradrenaline supply the spiral modiolar artery and suggest that they are involved in the regulation of cochlear blood flow.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690196     DOI: 10.1016/0378-5955(90)90219-f

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  9 in total

Review 1.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.

Authors:  Sophie Nyberg; N Joan Abbott; Xiaorui Shi; Peter S Steyger; Alain Dabdoub
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

2.  Molecular and pharmacological characteristics of the gerbil α(1a)-adrenergic receptor.

Authors:  Kelly M Witt; Charles S Bockman; Herbert K Dang; Daniel D Gruber; Philine Wangemann; Margaret A Scofield
Journal:  Hear Res       Date:  2011-11-10       Impact factor: 3.208

Review 3.  Physiopathology of the cochlear microcirculation.

Authors:  Xiaorui Shi
Journal:  Hear Res       Date:  2011-08-23       Impact factor: 3.208

4.  The expression of VIP and SP in the cochlea of spontaneously hypertensive rats and its implication.

Authors:  Shusheng Gong; Juan Ding; Qing Chang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

5.  Preventing internal auditory artery vasospasm using topical papaverine: an animal study.

Authors:  Krzysztof Morawski; Fred F Telischi; Faisal Merchant; Grzegorz Namyslowski; Grazyna Lisowska; Brenda L Lonsbury-Martin
Journal:  Otol Neurotol       Date:  2003-11       Impact factor: 2.311

6.  Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibers innervating cochlear and vertebro-basilar arteries.

Authors:  Z Vass; C F Dai; P S Steyger; G Jancsó; D R Trune; A L Nuttall
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Neuropeptide Y Expression Defines a Novel Class of GABAergic Projection Neuron in the Inferior Colliculus.

Authors:  Marina A Silveira; Justin D Anair; Nichole L Beebe; Pooyan Mirjalili; Brett R Schofield; Michael T Roberts
Journal:  J Neurosci       Date:  2020-05-06       Impact factor: 6.167

8.  Effects of Calcitonin-Gene-Related-Peptide on Auditory Nerve Activity.

Authors:  Colleen G Le Prell; Larry F Hughes; David F Dolan; Sanford C Bledsoe
Journal:  Front Cell Dev Biol       Date:  2021-11-12

9.  The mechanoelectrical transducer channel is not required for regulation of cochlear blood flow during loud sound exposure in mice.

Authors:  George W S Burwood; Suzan Dziennis; Teresa Wilson; Sarah Foster; Yuan Zhang; Gangjun Liu; Jianlong Yang; Sean Elkins; Alfred L Nuttall
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.